Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
11/02/2022

Archive: 11/02/2022

WHO prequalifies arthritis drug for severe COVID cases

The World Health Organization said Friday that it had prequalified the arthritis treatment tocilizumab for use in patients hospitalised with severe COVID-19, in a bid to increase access to the pricey drug.

Feb 11, 2022

0

13

US authorizes new antibody drug to fight omicron

U.S. health regulators on Friday authorized a new antibody drug that targets the omicron variant, a key step in restocking the nation's arsenal against the latest version of COVID-19.

Feb 11, 2022

0

5

Q&A: Surgeon General on omicron, masks and mental health

U.S. Surgeon General Vivek Murthy says he can imagine a future where Americans don't have to contend with mask requirements. But pulling back safeguards too quickly, Murthy warns, risks more avoidable suffering, especially ...

Feb 11, 2022

0

3

Researchers find new clues in the brain linking pain and food

It has long been known that there is an association between food and pain, as people with chronic pain often struggle with their weight. Researchers at the Del Monte Institute for Neuroscience may have found an explanation ...

Feb 11, 2022

0

1559

Interleukin-2 promotes fate decisions in CD8 T cells for long- or short-term immune protection

The immune system is a complex network of cells and proteins with a simple job: Defend the body against infection. To do that, the cells must recognize and destroy infecting viruses or bacteria. In addition, the system also ...

Feb 11, 2022

0

129

HIV incidence rising steeply among people who inject drugs in Tijuana

At the February 11, 2022 opening of the Conference on Retroviruses and Opportunistic Infection, researchers at University of California San Diego School of Medicine presented data that suggests a new HIV outbreak in Tijuana, ...

Feb 11, 2022

0

4

Oncology dietitians rarely ask cancer patients about food insecurity, study finds

Although studies suggest that many cancer patients experience food insecurity, few oncology dietitians routinely ask them if they are having problems affording or obtaining food, new research has found.

Feb 11, 2022

0

15

One in four adults reportedly skip care due to high costs

As part of an initiative funded by The John A. Hartford Foundation, FAIR Health conducted a nationwide study comprising two surveys geared toward older patients (adults 65 and older) and family caregivers/care partners. The ...

Feb 11, 2022

0

0

Diabetes, metabolic syndrome in mice treated with novel class of compounds

A study in mice—led by researchers at Washington University School of Medicine in St. Louis—shows that a new class of compounds the scientists developed can improve multiple aspects of metabolic syndrome. An increasingly ...

Feb 11, 2022

1

843

First study to show waning effectiveness of third dose of mRNA vaccines

A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity against severe COVID-19 disease begins to wane four months after receipt of the third dose of an mRNA vaccine ...

Feb 11, 2022

0

33

page 1 from 10

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2024 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us